PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 44 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 282.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $271,000 | -19.1% | 111,956 | +22.1% | 0.00% | – |
| Q2 2014 | $335,000 | -23.2% | 91,708 | -3.8% | 0.00% | – |
| Q1 2014 | $436,000 | +46.8% | 95,283 | +24.8% | 0.00% | – |
| Q4 2013 | $297,000 | -8.0% | 76,338 | +7.1% | 0.00% | – |
| Q3 2013 | $323,000 | +0.3% | 71,259 | +8.6% | 0.00% | – |
| Q2 2013 | $322,000 | – | 65,611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zhang Financial LLC | 45,000 | $36,000 | 0.02% |
| A.R.T. Advisors, LLC | 381,955 | $319,000 | 0.02% |
| Virtu KCG Holdings LLC | 705,907 | $591,000 | 0.02% |
| OXFORD ASSET MANAGEMENT LLP | 687,796 | $576,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 89,813 | $73,000 | 0.01% |
| FEDERATED HERMES, INC. | 1,945,682 | $1,630,000 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 324,479 | $272,000,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 302,588 | $253,000 | 0.00% |
| WEDBUSH SECURITIES INC | 23,000 | $19,000 | 0.00% |
| Renaissance Technologies | 2,300,800 | $1,927,000 | 0.00% |